Earnings Anticipation: Social media traders are gearing up for IonQ's earnings report next week, with active discussions around potential catalysts from quantum advancements. Some participants are betting on upside via call options, citing recent partnership executions as a positive signal. Premarket scans frequently list the stock alongside high-profile names, amplifying visibility.
Partnership Progress: Conversations highlight the swift movement in IonQ's collaboration with a leading regenerative medicine center, now advancing to hiring for a quantum-AI bio lab. Enthusiasts point to applications in drug discovery and bioprocess optimization as key to unlocking healthcare breakthroughs. This development fuels talk of IonQ's expanding role beyond pure research.
Technology Scrutiny: Skeptics counter with concerns over trapped-ion cooling costs versus emerging room-temperature rivals, labeling it a high-risk play against industry giants. Debates underscore the balance between IonQ's fidelity advantages and scalability hurdles. Sentiment captures cautious optimism amid competitive pressures.
Note: This discussion summary was generated from an AI condensation of post data.
IonQ Insider Trading Activity
IonQ insiders have traded $IONQ stock on the open market 9 times in the past 6 months. Of those trades, 1 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $IONQ stock by insiders over the last 6 months:
- RIMA ALAMEDDINE (Chief Revenue Officer) has made 0 purchases and 2 sales selling 119,976 shares for an estimated $5,576,026.
- THOMAS G. KRAMER (Chief Financial Officer) sold 64,578 shares for an estimated $2,700,858
- KATHRYN K. CHOU has made 0 purchases and 2 sales selling 25,000 shares for an estimated $1,302,980.
- MASI NICCOLO DE (President and CEO) sold 16,120 shares for an estimated $715,753
- ROBERT T. CARDILLO sold 8,773 shares for an estimated $443,191
- PAUL T DACIER (Chief Administrative Officer) sold 4,175 shares for an estimated $185,376
- WILLIAM J JR TEUBER purchased 2,000 shares for an estimated $109,630
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
IonQ Revenue
IonQ had revenues of $39.9M in Q3 2025. This is an increase of 221.5% from the same period in the prior year.
You can track IONQ financials on Quiver Quantitative's IONQ stock page.
IonQ Hedge Fund Activity
We have seen 435 institutional investors add shares of IonQ stock to their portfolio, and 269 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 7,595,514 shares (+33.8%) to their portfolio in Q4 2025, for an estimated $340,810,713
- MORGAN STANLEY removed 6,773,950 shares (-25.7%) from their portfolio in Q4 2025, for an estimated $303,947,136
- VANGUARD GROUP INC added 5,420,037 shares (+18.5%) to their portfolio in Q4 2025, for an estimated $243,197,060
- RENAISSANCE TECHNOLOGIES LLC removed 5,079,700 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $227,926,139
- D. E. SHAW & CO., INC. removed 4,568,803 shares (-83.9%) from their portfolio in Q4 2025, for an estimated $205,002,190
- MAREX GROUP PLC added 3,282,866 shares (+410.1%) to their portfolio in Q4 2025, for an estimated $147,302,197
- STATE STREET CORP added 2,663,230 shares (+42.3%) to their portfolio in Q4 2025, for an estimated $119,499,130
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IonQ Analyst Ratings
Wall Street analysts have issued reports on $IONQ in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 12/17/2025
- Mizuho issued a "Outperform" rating on 12/11/2025
- Cantor Fitzgerald issued a "Overweight" rating on 11/07/2025
- Rosenblatt issued a "Buy" rating on 11/06/2025
- Needham issued a "Buy" rating on 11/06/2025
- Benchmark issued a "Buy" rating on 09/16/2025
- B. Riley Securities issued a "Buy" rating on 09/15/2025
To track analyst ratings and price targets for IonQ, check out Quiver Quantitative's $IONQ forecast page.
IonQ Price Targets
Multiple analysts have issued price targets for $IONQ recently. We have seen 12 analysts offer price targets for $IONQ in the last 6 months, with a median target of $72.5.
Here are some recent targets:
- John McPeake from Rosenblatt set a target price of $100.0 on 02/06/2026
- N. Quinn Bolton from Needham set a target price of $80.0 on 01/27/2026
- Antoine Legault from Wedbush set a target price of $60.0 on 12/17/2025
- Kevin Garrigan from Jefferies set a target price of $100.0 on 12/16/2025
- Vijay Rakesh from Mizuho set a target price of $90.0 on 12/11/2025
- Peter Peng from JP Morgan set a target price of $47.0 on 11/20/2025
- Troy Jensen from Cantor Fitzgerald set a target price of $70.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
